Found: 117
Select item for more details and to access through your institution.
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN)
- Published in:
- Infection, 2019, v. 47, n. 1, p. 141, doi. 10.1007/s15010-018-1209-2
- By:
- Publication type:
- Article
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis.
- Published in:
- Infection, 2018, v. 46, n. 5, p. 607, doi. 10.1007/s15010-018-1157-x
- By:
- Publication type:
- Article
Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/580796
- By:
- Publication type:
- Article
Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives.
- Published in:
- Hepatic Medicine: Evidence & Research, 2014, v. 6, p. 25, doi. 10.2147/HMER.S44375
- By:
- Publication type:
- Article
Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered.
- Published in:
- Nutrients, 2019, v. 11, n. 12, p. 2971, doi. 10.3390/nu11122971
- By:
- Publication type:
- Article
Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection.
- Published in:
- Hepatitis Monthly, 2012, v. 12, n. 6, p. 411, doi. 10.5812/hepatmon.6135
- By:
- Publication type:
- Article
Treatment of Patients With HCV Related Cirrhosis: Many Rewards With Very Few Risks.
- Published in:
- Hepatitis Monthly, 2012, v. 12, n. 6, p. 361, doi. 10.5812/hepatmon.6095
- By:
- Publication type:
- Article
Ribavirin Impairs Salivary Gland Function in Hepatitis C Patients During Combination Treatment With Pegylated Interferon Alfa-2a.
- Published in:
- Hepatitis Monthly, 2011, v. 11, n. 11, p. 918, doi. 10.5812/kowsar.1735143X.733
- By:
- Publication type:
- Article
Immunosuppressive and antiviral treatment of hepatitis C virus-associated glomerular disease: A long-term follow-up.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
From Prioritization to Universal Treatment: Successes and Challenges of Hepatitis C Virus Elimination in Italy.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, p. S211, doi. 10.1093/infdis/jiad038
- By:
- Publication type:
- Article
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-39998-2
- By:
- Publication type:
- Article
Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.
- Published in:
- Journal of Viral Hepatitis, 2014, v. 21, n. 12, p. 944, doi. 10.1111/jvh.12281
- By:
- Publication type:
- Article
Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?
- Published in:
- 2008
- By:
- Publication type:
- Letter
Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir.
- Published in:
- Biologics: Targets & Therapy, 2012, v. 6, p. 363, doi. 10.2147/BTT.S20673
- By:
- Publication type:
- Article
Critical Care Outreach Team During COVID-19: Ventilatory Support in theWard and Outcomes.
- Published in:
- Respiratory Care, 2021, v. 66, n. 6, p. 928, doi. 10.4187/respcare.08743
- By:
- Publication type:
- Article
Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma.
- Published in:
- Internal & Emergency Medicine, 2012, v. 7, n. 2, p. 139, doi. 10.1007/s11739-011-0528-4
- By:
- Publication type:
- Article
Accuracy of FIB-4 to Detect Elevated Liver Stiffness Measurements in Patients with Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Referral Centers.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 20, p. 12489, doi. 10.3390/ijms232012489
- By:
- Publication type:
- Article
The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 5, p. 7213, doi. 10.3390/ijms15057213
- By:
- Publication type:
- Article
The first MASH drug therapy on the horizon: Current perspectives of resmetirom.
- Published in:
- Liver International, 2024, v. 44, n. 7, p. 1526, doi. 10.1111/liv.15930
- By:
- Publication type:
- Article
Prevalence of HCV infection in Europe in the DAA era: Review.
- Published in:
- Liver International, 2024, v. 44, n. 7, p. 1548, doi. 10.1111/liv.15981
- By:
- Publication type:
- Article
A territory‐wide opportunistic, hospital‐based HCV screening in the general population from northern Italy: The 1969–1989 birth‐cohort.
- Published in:
- Liver International, 2023, v. 43, n. 12, p. 2645, doi. 10.1111/liv.15727
- By:
- Publication type:
- Article
Forecasting the long‐term impact of COVID‐19 on hepatitis C elimination plans in Italy: A mathematical modelling approach.
- Published in:
- Liver International, 2023, v. 43, n. 12, p. 2615, doi. 10.1111/liv.15712
- By:
- Publication type:
- Article
Measuring the impact of the updated Steatotic liver disease nomenclature and definition.
- Published in:
- Liver International, 2023, v. 43, n. 11, p. 2340, doi. 10.1111/liv.15731
- By:
- Publication type:
- Article
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study.
- Published in:
- Liver International, 2023, v. 43, n. 7, p. 1440, doi. 10.1111/liv.15599
- By:
- Publication type:
- Article
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct‐acting antivirals.
- Published in:
- Liver International, 2023, v. 43, n. 7, p. 1593, doi. 10.1111/liv.15577
- By:
- Publication type:
- Article
Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between ChatGPT and the editors of Liver International.
- Published in:
- Liver International, 2023, v. 43, n. 5, p. 956, doi. 10.1111/liv.15580
- By:
- Publication type:
- Article
Liver biopsy is associated with increased body weight loss in patients with non‐alcoholic steatohepatitis.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2918, doi. 10.1111/liv.15420
- By:
- Publication type:
- Article
No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single centre in Milan.
- Published in:
- Liver International, 2022, v. 42, n. 12, p. 2921, doi. 10.1111/liv.15407
- By:
- Publication type:
- Article
No impact of COVID‐19 epidemic on decompensation of alcoholic liver disease: Results from a single‐centre in Milan.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2581, doi. 10.1111/liv.15400
- By:
- Publication type:
- Article
High prevalence of porto‐sinusoidal vascular disease in patients with constantly elevated gamma‐glutamyl transferase levels.
- Published in:
- Liver International, 2022, v. 42, n. 7, p. 1692, doi. 10.1111/liv.15257
- By:
- Publication type:
- Article
Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation.
- Published in:
- Liver International, 2022, v. 42, n. 1, p. 26, doi. 10.1111/liv.15070
- By:
- Publication type:
- Article
Management of liver disease in Italy after one year of the SARS‐CoV‐2 pandemic: A web‐based survey.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2228, doi. 10.1111/liv.14998
- By:
- Publication type:
- Article
COVID‐19 and the liver: A 2021 update.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 1988, doi. 10.1111/liv.14984
- By:
- Publication type:
- Article
High prevalence of multidrug‐resistant bacteria in patients with pyogenic liver abscess following liver cancer loco‐regional treatments.
- Published in:
- Liver International, 2021, v. 41, n. 8, p. 1909, doi. 10.1111/liv.14933
- By:
- Publication type:
- Article
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C.
- Published in:
- Liver International, 2021, v. 41, n. 8, p. 1802, doi. 10.1111/liv.14797
- By:
- Publication type:
- Article
Bulevirtide for treatment of patients with HDV infection and compensated cirrhosis: A (huge?) step in the right direction.
- Published in:
- Liver International, 2021, v. 41, n. 7, p. 1441, doi. 10.1111/liv.14967
- By:
- Publication type:
- Article
Is elimination of HCV realistic by 2030: France.
- Published in:
- Liver International, 2021, v. 41, p. 45, doi. 10.1111/liv.14862
- By:
- Publication type:
- Article
Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1227, doi. 10.1111/liv.14825
- By:
- Publication type:
- Article
Sofosbuvir in HCV patients with chronic kidney disease: No time for caution.
- Published in:
- Liver International, 2021, v. 41, n. 4, p. 646, doi. 10.1111/liv.14845
- By:
- Publication type:
- Article
Absolute targets for HCV elimination and national health policy paradigms: Foreseeing future requirements.
- Published in:
- Liver International, 2021, v. 41, n. 4, p. 649, doi. 10.1111/liv.14796
- By:
- Publication type:
- Article
Long‐term follow‐up of diabetic and non‐diabetic patients with chronic hepatitis C.
- Published in:
- Liver International, 2021, v. 41, n. 3, p. 640, doi. 10.1111/liv.14738
- By:
- Publication type:
- Article
Sarcopenia in chronic liver disease: easy to diagnose but hard to treat.
- Published in:
- Liver International, 2020, v. 40, n. 11, p. 2627, doi. 10.1111/liv.14690
- By:
- Publication type:
- Article
HCV screening: Moving from theory to practice.
- Published in:
- Liver International, 2020, v. 40, n. 7, p. 1538, doi. 10.1111/liv.14515
- By:
- Publication type:
- Article
COVID‐19 and liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 6, p. 1278, doi. 10.1111/liv.14470
- By:
- Publication type:
- Article
Issue Cover.
- Published in:
- Liver International, 2020, v. 40, n. 6, p. i, doi. 10.1111/liv.14444
- By:
- Publication type:
- Article
High rate of sustained virological response with direct‐acting antivirals in haemophiliacs with HCV infection: A multicenter study.
- Published in:
- Liver International, 2020, v. 40, n. 5, p. 1062, doi. 10.1111/liv.14337
- By:
- Publication type:
- Article
Do gamma‐glutamyltransferase levels identify HCV patients who require lifelong post‐SVR follow‐up?
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 509, doi. 10.1111/liv.14394
- By:
- Publication type:
- Article
Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 778, doi. 10.1111/liv.14266
- By:
- Publication type:
- Article